| (PDPN) | podoplanin |
| (CAFs) | cancer-associated fibroblasts |
| (EMT) | epithelial-mesenchymal transition |
| (ADCC) | antibody-dependent cellular cytotoxic |
| (CHO) | chinese hamster ovary |
| (CasMab) | cancer-specific monoclonal antibody |
| (dPDPN) | canine PDPN |
| (mAb) | monoclonal antibody |
| (P38Bf) | a cancer-specific mouse–dog chimeric anti-PDPN antibody |
| (FBS) | fetal bovine serum |
| (PSA) | penicillin, streptomycin, and amphotericin B |
| (CHO/dPDPN) | canine PDPN-expressing CHO-K1 with N-terminal PA tag |
| (IgG) | immunoglobulin G |
| (ELISA) | enzyme-linked immunosorbent assay |
| (FACS) | fluorescence-activated cell sorting |
| (PBS) | phosphate buffered saline |
| (LAK) | lymphokine-activated killer |
| (IL-2) | interleukin-2 |
| (RLU) | relative light units |
| (CBC) | complete blood count |
| (ALB) | albumin |
| (ALP) | alkaline phosphatase |
| (BUN) | blood urea nitrogen |
| (Ca) | calcium |
| (CRE) | creatinine |
| (CRP) | c-reactive protein |
| (Na, K, Cl) | electrolytes |
| (GFR) | glomerular filtration rate |
| (GGT) | γ-glutamyltransferase |
| (GLU) | glucose |
| (GOT) | glutamic oxaloacetic transaminase; glutamic-oxaloacetic transaminase |
| (GPT) | glutamic pyruvic transaminase |
| (TBIL) | total bilirubin |
| (TCHO) | total cholesterol |
| (TG) | triglycerides |
| (TP) | total protein |
| (vLIP) | lipase |
| (iP) | inorganic phosphorus |
| (SpO2) | percutaneous oxygen saturation |
| (CT) | computed tomography |
| (VCOG-CTCAE) | Veterinary Cooperative Oncology Group—Common Terminology Criteria for Adverse Events |
| (TBST) | tris-buffered saline with 0.1% Tween® 20 detergent |
| (VMC) | Veterinary Medical Center |
| (RECIST) | response evaluation criteria for solid tumors |
| (SE) | standard error |
| (CR) | complete response |
| (PR) | partial response |
| (SD) | stable disease |
| (PD) | progressive disease |
| (NK) | natural killer |
| (ADC) | Antibody–drug conjugate |
| (CAR) | chimeric antigen receptor |